Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: Magnesium Sulfate Versus 5% Dextrose With Treatment Resistant Depression [NA]
The trial comparing magnesium sulfate to 5% dextrose for treatment-resistant depression has completed; the summary does not include efficacy…
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: Pain Processing in Anxiety and Depression
A completed clinical trial run by the Danish Pain Research Center examining how pain processing relates to anxiety and depression.
-
FDA approval · 2016-01-20FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approves a supplemental application for venlafaxine hydrochloride submitted by Zydus Pharmaceuticals USA Inc., resulting in regulatory a…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Functional Neuroanatomy and Regional Metabolism Before and After Treatment With Duloxetine
This clinical trial update investigates functional neuroanatomy and regional metabolism in major depressive disorder before and after treatm…
-
FDA approval · 2016-01-20FDA Approved: DOXEPIN — Original Application (North Star Rx LLC)
FDA approved North Star Rx LLC's generic doxepin through an Original Application, marking the approval of a generic doxepin product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Transcranial Direct Current Stimulation as an Augmenting Intervention for Major Depression [Phase 2, Phase 3]
This entry summarizes a clinical trial update on using transcranial direct current stimulation as an augmenting therapy for Major depressive…
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients
A postmarketing surveillance study of desvenlafaxine succinate (Pristiq) in Filipino patients with major depressive disorder and vasomotor s…
-
CLINICAL_TRIALS trial_result · 2016-01-15Clinical Trial Update: Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder [Phase 2]
This Phase 2 study reports pharmacokinetics and tolerability of vortioxetine in children and adolescents with depressive or anxiety disorder…
-
CLINICAL_TRIALS trial_result · 2016-01-15Clinical Trial Update: Pharmacotherapy in Depression With Panic Spectrum [Phase 4]
Phase 4 clinical trial update for pharmacotherapy in major depressive disorder with panic-spectrum; the study has completed. No specific dru…
-
CLINICAL_TRIALS trial_result · 2016-01-15Clinical Trial Update: MOMCare: Culturally Relevant Treatment Services for Perinatal Depression [NA]
This completed clinical trial evaluated MOMCare, a culturally relevant treatment program for perinatal depression, sponsored by the Universi…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Prediction of Quality of Life in Cardiovascular Disease
Completed clinical trial evaluating prediction of quality of life in patients with cardiovascular disease. The study encompassed conditions …
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Vigorous Exercise for Depressed Smokers [NA]
A Mayo Clinic-sponsored trial studied the effects of vigorous exercise on depression and nicotine dependence in smokers, and the study statu…
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression [Phase 3]
Phase 3 trial assessing the effectiveness of interpersonal psychotherapy for major depressive disorder in male and female prisoners; study c…
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss [NA]
A completed clinical trial evaluated group interpersonal psychotherapy for treating major depressive disorder after perinatal loss (miscarri…
-
CLINICAL_TRIALS research · 2016-01-13Clinical Trial Update: Epidemiology of Cardiovascular Risk Factors in Women (Healthy Women Study)
A completed epidemiology study conducted by the University of Pittsburgh examining cardiovascular risk factors in women, including associati…
-
FDA approval · 2016-01-12FDA Approved: FLUOXETINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for fluoxetine from Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Impact of Immune Challenge on Triple Network Connectivity in Humans [NA]
This clinical trial update reports on a study investigating how an immune challenge affects triple network connectivity in humans, with majo…
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices [NA]
A completed clinical trial evaluated the effectiveness of low-cost devices in improving patient adherence across multiple conditions. The up…
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: Health Promotion in Early Adolescence: Sleep, Activity, and Emotion Regulation [NA]
This completed clinical trial evaluated a health-promotion program in early adolescence focusing on sleep, physical activity, and emotion re…
-
FDA label_change · 2016-01-10FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for fluoxetine from Teva Pharmaceuticals USA, Inc. to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression [Phase 2]
Phase 2 trial update analyzing the efficacy and safety of mirtazapine in patients with non-small cell lung cancer and depression.
-
CLINICAL_TRIALS trial_result · 2016-01-07Clinical Trial Update: Study of Genes in Relation to Seasonal Affective Disorder and Major Depressive Disorder
A completed University of Pittsburgh study investigated genetic factors related to Seasonal Affective Disorder and Major Depressive Disorder…
-
FDA approval · 2016-01-05FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Escitalopram Oxalate from Rising Pharma Holdings, Inc., confirming continued approval of thi…
-
CLINICAL_TRIALS withdrawal · 2016-01-05Clinical Trial Update: e-PAT Neuromod Evaluation of Personalized rTMS for Resistant Depression [Phase 2]
A Phase 2 clinical trial evaluating personalized e-PAT neuromodulation with repetitive transcranial magnetic stimulation for treatment-resis…
-
FDA approval · 2016-01-04FDA Approved: QUETIAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for a generic quetiapine product from Teva Pharmaceuticals USA, Inc.